| Mohammad Samer Younes, MD | |
|
99 Woodland Street, Hartford, CT 06105 | |
| (860) 714-7527 | |
| Not Available |
| Full Name | Mohammad Samer Younes |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 4 Years |
| Location | 99 Woodland Street, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114455987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD17061 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home & Hospice Care Of Rhode Island | Providence, RI | Hospice |
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Chartercare Physicians Llc | 0840416657 | 83 |
News Archive
A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.
Researchers in the UK have warned that healthcare professionals and providers need to consider how Advance Care Planning (ACP) can be resourced and normalized as part of standard care during the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ahead of recurrent or future waves.
Vical Incorporated today announced that its prophylactic Vaxfectin®-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against lethal challenge, provided sterilizing immunity and inhibited viral counts at both the primary and latent infection sites. The Vaxfectin® adjuvant substantially improved vaccine effectiveness. A related vaccine significantly reduced the recurrence of HSV-2 lesions in a therapeutic model using guinea pigs with latent infection.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing program designed to detect and stop the abnormal heart rhythms that precede syncope had a seven-fold reduction in fainting compared with patients in a placebo pacing group, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 1 days ago
| Entity Name | Prospect Chartercare Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629493135 PECOS PAC ID: 0840416657 Enrollment ID: O20140730001883 |
News Archive
A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.
Researchers in the UK have warned that healthcare professionals and providers need to consider how Advance Care Planning (ACP) can be resourced and normalized as part of standard care during the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ahead of recurrent or future waves.
Vical Incorporated today announced that its prophylactic Vaxfectin®-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against lethal challenge, provided sterilizing immunity and inhibited viral counts at both the primary and latent infection sites. The Vaxfectin® adjuvant substantially improved vaccine effectiveness. A related vaccine significantly reduced the recurrence of HSV-2 lesions in a therapeutic model using guinea pigs with latent infection.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing program designed to detect and stop the abnormal heart rhythms that precede syncope had a seven-fold reduction in fainting compared with patients in a placebo pacing group, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Samer Younes, MD 41 Sanderson Rd, Smithfield, RI 02917-2602 Ph: (401) 456-2525 | Mohammad Samer Younes, MD 99 Woodland Street, Hartford, CT 06105 Ph: (860) 714-7527 |
News Archive
A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.
Researchers in the UK have warned that healthcare professionals and providers need to consider how Advance Care Planning (ACP) can be resourced and normalized as part of standard care during the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ahead of recurrent or future waves.
Vical Incorporated today announced that its prophylactic Vaxfectin®-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against lethal challenge, provided sterilizing immunity and inhibited viral counts at both the primary and latent infection sites. The Vaxfectin® adjuvant substantially improved vaccine effectiveness. A related vaccine significantly reduced the recurrence of HSV-2 lesions in a therapeutic model using guinea pigs with latent infection.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing program designed to detect and stop the abnormal heart rhythms that precede syncope had a seven-fold reduction in fainting compared with patients in a placebo pacing group, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 1 days ago
Nicole Poole, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 Woodland St, Hartford, CT 06105 Phone: 860-714-7527 | |
Robin B. Gold, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 Woodland St, Asylum Hill Family Medicine Center, Inc, Hartford, CT 06105 Phone: 860-714-4212 Fax: 860-714-8080 | |
Joshua M Jones, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 43 Woodland St, Hartford, CT 06105 Phone: 888-793-3500 | |
Robert A Cushman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 99 Woodland St, Hartford, CT 06105 Phone: 860-714-4212 Fax: 860-714-8080 | |
Dr. Marcos Alfonso Iglesias, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Tower Sq # Ms 07, Hartford, CT 06183 Phone: 860-461-8733 | |
Dr. Christine Judith Warner-morin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St Bldg 502, Hartford, CT 06102 Phone: 860-972-9033 Fax: 860-972-7040 |